Cargando…
Immune checkpoint inhibitors in lung cancer: the holy grail has not yet been found…
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
ESMO Open
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519814/ https://www.ncbi.nlm.nih.gov/pubmed/28761734 http://dx.doi.org/10.1136/esmoopen-2017-000162 |
| _version_ | 1783251700775124992 |
|---|---|
| author | Thungappa, Satheesh Ferri, Jose Caglevic, Christian Passiglia, Francesco Raez, Luis Rolfo, Christian |
| author_facet | Thungappa, Satheesh Ferri, Jose Caglevic, Christian Passiglia, Francesco Raez, Luis Rolfo, Christian |
| author_sort | Thungappa, Satheesh |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5519814 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | ESMO Open |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-55198142017-07-31 Immune checkpoint inhibitors in lung cancer: the holy grail has not yet been found… Thungappa, Satheesh Ferri, Jose Caglevic, Christian Passiglia, Francesco Raez, Luis Rolfo, Christian ESMO Open Editorial ESMO Open 2017-03-27 /pmc/articles/PMC5519814/ /pubmed/28761734 http://dx.doi.org/10.1136/esmoopen-2017-000162 Text en © European Society for Medical Oncology (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| spellingShingle | Editorial Thungappa, Satheesh Ferri, Jose Caglevic, Christian Passiglia, Francesco Raez, Luis Rolfo, Christian Immune checkpoint inhibitors in lung cancer: the holy grail has not yet been found… |
| title | Immune checkpoint inhibitors in lung cancer: the holy grail has not yet been found… |
| title_full | Immune checkpoint inhibitors in lung cancer: the holy grail has not yet been found… |
| title_fullStr | Immune checkpoint inhibitors in lung cancer: the holy grail has not yet been found… |
| title_full_unstemmed | Immune checkpoint inhibitors in lung cancer: the holy grail has not yet been found… |
| title_short | Immune checkpoint inhibitors in lung cancer: the holy grail has not yet been found… |
| title_sort | immune checkpoint inhibitors in lung cancer: the holy grail has not yet been found… |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519814/ https://www.ncbi.nlm.nih.gov/pubmed/28761734 http://dx.doi.org/10.1136/esmoopen-2017-000162 |
| work_keys_str_mv | AT thungappasatheesh immunecheckpointinhibitorsinlungcancertheholygrailhasnotyetbeenfound AT ferrijose immunecheckpointinhibitorsinlungcancertheholygrailhasnotyetbeenfound AT caglevicchristian immunecheckpointinhibitorsinlungcancertheholygrailhasnotyetbeenfound AT passigliafrancesco immunecheckpointinhibitorsinlungcancertheholygrailhasnotyetbeenfound AT raezluis immunecheckpointinhibitorsinlungcancertheholygrailhasnotyetbeenfound AT rolfochristian immunecheckpointinhibitorsinlungcancertheholygrailhasnotyetbeenfound |